Recurrent COVID‐19 infection in a case of rituximab‐induced hypogammaglobulinaemia

Patients with immunodeficiency are at an increased risk of recurrent COVID‐19 infection. They may lack the natural immune response that usually confers long‐lasting immunity. Here, we present our experience managing one such patient, who had a COVID‐19 infection twice, 5 months apart. He had a posit...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniel, Jefferson, Thangakunam, Balamugesh, Isaac, Barney Thomas Jesudason, Moorthy, Mahesh, Christopher, Devasahayam Jesudas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652043/
https://www.ncbi.nlm.nih.gov/pubmed/34934508
http://dx.doi.org/10.1002/rcr2.891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652043/
https://www.ncbi.nlm.nih.gov/pubmed/34934508
http://dx.doi.org/10.1002/rcr2.891

Ejemplares similares